Publications by authors named "Jack Higgins"

Claim this Profile
C
Communication regarding the deactivation of implantable cardioverter-defibrillators: A scoping review and narrative summary of current interventions.
Ellen M Callaghan, Elly Diamandis-Nikoletatos, Paul P van Leeuwen, Jack B Higgins, Christine E Somerville

Patient Educ Couns· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma.
Paul A Hamlin, Vasile Musteata, Steven I Park, Christine Burnett, Kristina Dabovic, Jack P Higgins

Cancer Res Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies.
Aparna Hegde, Priyamvada Jayaprakash, Coline A Couillault, Sarina Piha-Paul, Daniel Karp, Jack P Higgins

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression.
Sofia R Gameiro, Jack P Higgins, Matthew R Dreher, David L Woods, Goutham Reddy

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy.
Benedetto Farsaci, Jack P Higgins, James W Hodge

Int J Cancer· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses.
Sofia R Gameiro, Jorge A Caballero, Jack P Higgins, David Apelian, James W Hodge

Cancer Immunol Immunother· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccines based on whole recombinant Saccharomyces cerevisiae cells.
Andressa Ardiani, Jack P Higgins, James W Hodge

FEMS Yeast Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine.
Benedetto Farsaci, Helen Sabzevari, Jack P Higgins, Maria Giovanna Di Bari, Shinji Takai

Int J Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.
James L Gulley, Philip M Arlen, Ravi A Madan, Kwong-Yok Tsang, Mary P Pazdur, Jack P Higgins

Cancer Immunol Immunother· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent vaccination with two distinct vaccine platforms targeting the same antigen generates phenotypically and functionally distinct T-cell populations.
Amanda L Boehm, Jack Higgins, Alex Franzusoff, Jeffrey Schlom, James W Hodge

Cancer Immunol Immunother· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing immune responses to tumor-associated antigens.
Jack P Higgins, Michael B Bernstein, James W Hodge

Cancer Biol Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen.
James W Hodge, Jack Higgins, Jeffrey Schlom

Vaccine· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma.
James L Gulley, Philip M Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Jack P Higgins

Clin Cancer Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel retrograde-viewing auxiliary imaging device (Third Eye Retroscope) improves the detection of simulated polyps in anatomic models of the colon.
George Triadafilopoulos, H David Watts, Jack Higgins, Jacques Van Dam

Gastrointest Endosc· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis